| Supplemental data |
The following information is presented as supplemental data as required by the indentures governing our senior notes.
Condensed Consolidating Statements of Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Company and |
|
|
|
|
Consolidated |
|
|
Physician |
|
|
Unrestricted |
|
|
Restricted |
|
|
For the three months ended March 31, 2015 |
|
Total |
|
|
Groups |
|
|
Subsidiaries |
|
|
Subsidiaries(1) |
|
|
Patient service operating revenues |
|
$ |
2,271,815 |
|
|
$ |
29,654 |
|
|
$ |
— |
|
|
$ |
2,242,161 |
|
|
Less: Provision for uncollectible accounts |
|
|
(99,164 |
) |
|
|
(289 |
) |
|
|
— |
|
|
|
(98,875 |
) |
|
Net patient service operating revenues |
|
|
2,172,651 |
|
|
|
29,365 |
|
|
|
— |
|
|
|
2,143,286 |
|
|
Capitated revenues |
|
|
850,515 |
|
|
|
386,331 |
|
|
|
— |
|
|
|
464,184 |
|
|
Other revenues |
|
|
264,799 |
|
|
|
919 |
|
|
|
— |
|
|
|
263,880 |
|
|
Total net operating revenues |
|
|
3,287,965 |
|
|
|
416,615 |
|
|
|
— |
|
|
|
2,871,350 |
|
|
Operating expenses |
|
|
3,352,121 |
|
|
|
409,306 |
|
|
|
(237 |
) |
|
|
2,943,052 |
|
|
Operating (loss) income |
|
|
(64,156 |
) |
|
|
7,309 |
|
|
|
237 |
|
|
|
(71,702 |
) |
|
Debt expense, including refinancing charges |
|
|
(97,392 |
) |
|
|
(2,464 |
) |
|
|
— |
|
|
|
(94,928 |
) |
|
Other (loss) income |
|
|
(533 |
) |
|
|
30 |
|
|
|
— |
|
|
|
(563 |
) |
|
Income tax (benefit) expense |
|
|
(85,933 |
) |
|
|
1,489 |
|
|
|
95 |
|
|
|
(87,517 |
) |
|
Net (loss) income |
|
|
(76,148 |
) |
|
|
3,386 |
|
|
|
142 |
|
|
|
(79,676 |
) |
|
Less: Net income attributable to noncontrolling interests |
|
|
(34,469 |
) |
|
|
— |
|
|
|
— |
|
|
|
(34,469 |
) |
|
Net (loss) income attributable to DaVita HealthCare Partners
Inc. |
|
$ |
(110,617 |
) |
|
$ |
3,386 |
|
|
$ |
142 |
|
|
$ |
(114,145 |
) |
|
(1) |
After the elimination of the unrestricted subsidiaries and the physician groups |
Condensed Consolidating Statements of Comprehensive Income
|
|
|
|
|
|
|
|
|
|
|
Company and |
|
|
|
|
Consolidated |
|
|
Physician |
|
|
Unrestricted |
|
|
Restricted |
|
|
For the three months ended March 31, 2015 |
|
Total |
|
|
Groups |
|
|
Subsidiaries |
|
|
Subsidiaries(1) |
|
|
Net (loss) income |
|
$ |
(76,148 |
) |
|
$ |
3,386 |
|
|
$ |
142 |
|
|
$ |
(79,676 |
) |
|
Other comprehensive loss |
|
|
(22,608 |
) |
|
|
— |
|
|
|
— |
|
|
|
(22,608 |
) |
|
Total comprehensive (loss) income |
|
|
(98,756 |
) |
|
|
3,386 |
|
|
|
142 |
|
|
|
(102,284 |
) |
|
Less: comprehensive income attributable to the noncontrolling
interests |
|
|
(34,469 |
) |
|
|
— |
|
|
|
— |
|
|
|
(34,469 |
) |
|
Comprehensive (loss) income attributable to DaVita HealthCare
Partners Inc. |
|
$ |
(133,225 |
) |
|
$ |
3,386 |
|
|
$ |
142 |
|
|
$ |
(136,753 |
) |
|
(1) |
After the elimination of the unrestricted subsidiaries and the physician groups |
Condensed Consolidating Balance Sheets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Company and |
|
|
|
|
Consolidated |
|
|
Physician |
|
|
Unrestricted |
|
|
Restricted |
|
|
As of March 31, 2015 |
|
Total |
|
|
Groups |
|
|
Subsidiaries |
|
|
Subsidiaries(1) |
|
|
Cash and cash equivalents |
|
$ |
1,011,271 |
|
|
$ |
101,416 |
|
|
$ |
— |
|
|
$ |
909,855 |
|
|
Accounts receivable, net |
|
|
1,675,182 |
|
|
|
255,659 |
|
|
|
— |
|
|
|
1,419,523 |
|
|
Other current assets |
|
|
1,614,342 |
|
|
|
9,376 |
|
|
|
— |
|
|
|
1,604,966 |
|
|
Total current assets |
|
|
4,300,795 |
|
|
|
366,451 |
|
|
|
— |
|
|
|
3,934,344 |
|
|
Property and equipment, net |
|
|
2,500,596 |
|
|
|
2,212 |
|
|
|
— |
|
|
|
2,498,384 |
|
|
Amortizable intangibles, net |
|
|
1,904,176 |
|
|
|
7,385 |
|
|
|
— |
|
|
|
1,896,791 |
|
|
Other long-term assets |
|
|
229,706 |
|
|
|
69,461 |
|
|
|
3,048 |
|
|
|
157,197 |
|
|
Goodwill |
|
|
9,431,390 |
|
|
|
15,155 |
|
|
|
— |
|
|
|
9,416,235 |
|
|
Total assets |
|
$ |
18,366,663 |
|
|
$ |
460,664 |
|
|
$ |
3,048 |
|
|
$ |
17,902,951 |
|
|
Current liabilities |
|
$ |
2,679,516 |
|
|
$ |
195,987 |
|
|
$ |
— |
|
|
$ |
2,483,529 |
|
|
Payables to parent |
|
|
— |
|
|
|
186,830 |
|
|
|
3,048 |
|
|
|
(189,878 |
) |
|
Long-term debt and other long-term liabilities |
|
|
9,668,041 |
|
|
|
57,470 |
|
|
|
— |
|
|
|
9,610,571 |
|
|
Noncontrolling interests subject to put provisions |
|
|
848,392 |
|
|
|
— |
|
|
|
— |
|
|
|
848,392 |
|
|
Total DaVita HealthCare Partners Inc. shareholders’ equity |
|
|
4,971,410 |
|
|
|
20,377 |
|
|
|
— |
|
|
|
4,951,033 |
|
|
Noncontrolling interests not subject to put provisions |
|
|
199,304 |
|
|
|
— |
|
|
|
— |
|
|
|
199,304 |
|
|
Shareholders’ equity |
|
|
5,170,714 |
|
|
|
20,377 |
|
|
|
— |
|
|
|
5,150,337 |
|
|
Total liabilities and shareholder’s equity |
|
$ |
18,366,663 |
|
|
$ |
460,664 |
|
|
$ |
3,048 |
|
|
$ |
17,902,951 |
|
|
(1) |
After the elimination of the unrestricted subsidiaries and the physician groups |
Condensed Consolidating Statements of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Company and |
|
|
|
|
Consolidated |
|
|
Physician |
|
|
Unrestricted |
|
|
Restricted |
|
|
For the three months ended March 31, 2015 |
|
Total |
|
|
Groups |
|
|
Subsidiaries |
|
|
Subsidiaries(1) |
|
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income |
|
$ |
(76,148 |
) |
|
$ |
3,386 |
|
|
$ |
142 |
|
|
$ |
(79,676 |
) |
|
Changes in operating and intercompany assets and liabilities
and non-cash items included in net income |
|
|
486,237 |
|
|
|
(16,884 |
) |
|
|
(142 |
) |
|
|
503,263 |
|
|
Net cash provided by (used in) operating activities |
|
|
410,089 |
|
|
|
(13,498 |
) |
|
|
— |
|
|
|
423,587 |
|
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additions of property and equipment |
|
|
(121,421 |
) |
|
|
164 |
|
|
|
— |
|
|
|
(121,585 |
) |
|
Acquisitions and divestitures, net |
|
|
(40,650 |
) |
|
|
— |
|
|
|
— |
|
|
|
(40,650 |
) |
|
Proceeds from discontinued operations |
|
|
2,565 |
|
|
|
— |
|
|
|
— |
|
|
|
2,565 |
|
|
Investments and other items |
|
|
(92,781 |
) |
|
|
(457 |
) |
|
|
— |
|
|
|
(92,324 |
) |
|
Net cash used in investing activities |
|
|
(252,287 |
) |
|
|
(293 |
) |
|
|
— |
|
|
|
(251,994 |
) |
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term debt |
|
|
(28,439 |
) |
|
|
— |
|
|
|
— |
|
|
|
(28,439 |
) |
|
Intercompany |
|
|
— |
|
|
|
2,759 |
|
|
|
— |
|
|
|
(2,759 |
) |
|
Other items |
|
|
(82,429 |
) |
|
|
— |
|
|
|
— |
|
|
|
(82,429 |
) |
|
Net cash used in by financing activities |
|
|
(110,868 |
) |
|
|
2,759 |
|
|
|
— |
|
|
|
(113,627 |
) |
|
Effect of exchange rate changes on cash |
|
|
(904 |
) |
|
|
— |
|
|
|
— |
|
|
|
(904 |
) |
|
Net increase (decrease) in cash |
|
|
46,030 |
|
|
|
(11,032 |
) |
|
|
— |
|
|
|
57,062 |
|
|
Cash and cash equivalents at beginning of period |
|
|
965,241 |
|
|
|
112,448 |
|
|
|
— |
|
|
|
852,793 |
|
|
Cash and cash equivalents at end of period |
|
$ |
1,011,271 |
|
|
$ |
101,416 |
|
|
$ |
— |
|
|
$ |
909,855 |
|
|
(1) |
After the elimination of the unrestricted subsidiaries and the physician groups | |